Charles Schwab’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Buy
46,855
+28,654
+157% +$97.2K ﹤0.01% 3398
2026
Q1
$76.1K Sell
18,201
-9,140
-33% -$38.1K ﹤0.01% 3405
2025
Q4
$118K Buy
27,341
+13,074
+92% +$49.9K ﹤0.01% 3389
2025
Q3
$61.9K Hold
14,267
﹤0.01% 3416
2025
Q2
$66.2K Buy
+14,267
New +$56.4K ﹤0.01% 3436

Other funds holding SBC

Charles Schwab's SBC Position: Q2 2026 in Review

Charles Schwab increased its SBC Medical Group (SBC) stake by 157% in Q2 2026, buying an estimated $97.2K and bringing the position to 46,855 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3398.

Charles Schwab first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Charles Schwab held 46,855 shares of SBC Medical Group worth $144K as of Q2 2026.
  • Charles Schwab bought 28,654 SBC Medical Group shares in Q2 2026, an estimated $97.2K.
  • SBC Medical Group made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3398 holding.
  • Charles Schwab first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.